Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2 Other hematologic neoplasm 1 Myeloid 1 Genitourinary 1 Gastrointestinal 1

Conditions

Polycythemia Vera 1

Interventions

Imatinib Mesylate 28 nilotinib 21 Cytarabine 21 Methotrexate 16 Hydroxyurea 15 Cyclophosphamide 15 Busulfan 15 Peripheral Blood Stem Cell Transplantation 13 ruxolitinib 11 Etoposide 11 Whole-Body Irradiation 10 fludarabine phosphate 9 fludarabine 9 Tacrolimus 9 Mycophenolic Acid 9 Daunorubicin 9 Idarubicin 8 Radiotherapy 7 Mitoxantrone 7 Interferon-alpha 7 Cyclosporine 6 peginterferon alfa-2a 5 bosutinib 5 asciminib 5 Melphalan 5 Azacitidine 5 merphos 4 luspatercept 4 Thioguanine 4 Filgrastim 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Interferons × Myeloid × Clear all

NCT04116502 2026-04-28

MITHRIDATE

University of Birmingham

Phase 3 Recruiting

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡